Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, Manufactured by: Lupin Limited Nagpur-441 108, INDIA, NDC 68180-519-01
Published July 23, 2025 · Recall initiated: June 20, 2025
Summary
FDA records drug Class II recall D-0532-2025, published July 23, 2025 and initiated June 20, 2025. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Ongoing; Reported quantity: 58,968 bottles; Lot: Lot #: QA01081, Exp. Date April 2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
What to do
Voluntary: Firm initiated
Get an email if LISINOPRIL AND HYDROCHLOROTHIAZIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LISINOPRIL AND HYDROCHLOROTHIAZIDE
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Product was distributed nationwide within the United States.
- UPC
- 0368180519010
- Lot
- Lot #: QA01081, Exp. Date April 2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPERIPHERAL PARENTERAL NUTRITION, Compounded Sterile Preparation, Refrigerated Injection, Rx Only, Single DoseJuly 23, 2025
- FDARizatriptan Benzoate Tablets, USP, 5 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: AlkemJuly 23, 2025
- FDAOmeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy'sJuly 23, 2025
- FDALisinopril and Hydrochlorothiazide Tablets USP, 10mg/12.5mg, Rx only, 100 Tablets per bottles, ManufacturedJanuary 3, 2024
- FDALisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg, 500-count bottle, Rx only, Manufactured for:July 31, 2019
- FDALisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg, packaged in a)100-count bottles and b) 5000-countJuly 6, 2016
Questions about this recall
Was Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, Manufactured by: Lupin Limited Nagpur-441 108, INDIA, NDC 68180-519-01 recalled?
Yes. FDA published recall D-0532-2025 on July 23, 2025. Reported hazard: Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LISINOPRIL AND HYDROCHLOROTHIAZIDE. UPC: 0368180519010.